Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...

The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late Monday. The facility, with a net ...

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

It follows 24-week results reported earlier this year and means that the new regimen will now advance into a phase 3 programme, said Gilead and MSD, known as Merck & Co in the US and Canada.

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and ...

Kovalenko scored a goal Saturday in a 3-2 win over New Jersey. Kovalenko's goal was his first for San Jose since being acquired from Colorado on Dec. 9. He drove the net and fired low through ...

US to build new stockpile of bird flu vaccine for poultry Healthcare & Pharmaceuticalscategory· January 8, 2025 Merck's human papillomavirus vaccine has been approved for men in China ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Copyright: © 2024 Published by Elsevier Ltd. In The Lancet Oncology, Dan-Yun Ruan and colleagues reported the phase 1 trial results of CMG901, a CLD18.2-directed ...